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ABSTRACT
Objective: To examine patients’ experiences of
information and support provision for age-related
macular degeneration (AMD) in the UK.
Study design: Exploratory qualitative study
investigating patient experiences of healthcare
consultations and living with AMD over 18 months.
Setting: Specialist eye clinics at a Birmingham
hospital.
Participants: 13 patients diagnosed with AMD.
Main outcome measures: Analysis of patients’
narratives to identify key themes and issues relating to
information and support needs.
Results: Information was accessed from a variety of
sources. There was evidence of clear information
deficits prior to diagnosis, following diagnosis and
ongoing across the course of the condition. Patients
were often ill informed and therefore unable to self-
advocate and recognise when support was needed,
what support was available and how to access support.
Conclusions: AMD patients have a variety of
information needs that are variable across the course
of the condition. Further research is needed to
determine whether these experiences are typical and
identify ways of translating the guidelines into practice.
Methods of providing information need to be
investigated and improved for this patient group.
INTRODUCTION
Sight loss affects one in ﬁve people over the
age of 75 and one in two people over the
age of 90.1 Age-related macular degeneration
(AMD) is a condition that causes loss of
central vision and in high-income countries
accounts for over a half of blind registra-
tions.2 Cases with late or advanced AMD can
be associated with a profound loss of central
vision, and are classiﬁed into geographic
atrophy (GA), so-called ‘dry’ AMD, and neo-
vascular cases (NVAMD), so-called ‘wet’
AMD. Recent meta-analysis studies of the epi-
demiology of AMD have shown that when
the late AMD group is examined in large
population studies, the prevalence of GA and
NVAMD are equal.3 Although the treatment
of dry AMD remains of limited or no beneﬁt,
there have been major breakthroughs in the
management of wet AMD. Intravitreal ranibi-
zumab injection, an antiangiogenic treat-
ment, is the approved treatment for wet
AMD in the UK4 and has been very success-
ful.5 Delays in treatment for wet AMD may
lead to signiﬁcantly reduced visual acuity6
and as patients with dry AMD may also
develop wet AMD, it is important that wet
AMD is diagnosed as quickly as possible in
this patient group.
The Royal College of Ophthalmologists’7
existing guidelines for the management of
AMD patients in the UK include recommen-
dations for diagnosis, treatment and
Strengths and limitations of this study
▪ A frequent criticism of qualitative research is the
relatively small sample size. However, qualitative
methods traditionally use smaller samples to
ensure that the depth and detail of participant
accounts can be fully understood.
▪ This sample included patients with a range of
age-related macular degeneration conditions and
all participants highlighted a variety of informa-
tion deficits experienced. As all participants
experienced elements of information deficit this
lends support to our arguments regarding
improved information provision for patients.
▪ This study highlights that current recommenda-
tions for verbal and written methods of informa-
tion provision are unsuitable for older patients
with vision impairment and illustrates that the
development of new methods for providing infor-
mation to these patients is required.
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management. Speciﬁc recommendations include the
early provision of verbal and written information about
the condition, available rehabilitation and contacts for
other services. The guidelines state that all patients
should receive: a clear diagnosis (knowing the name of
their condition and where to seek further information
and advice); vision prognosis (whether it might develop
in the second eye and might ‘dry’ become ‘wet’); treat-
ment options, if they exist, and other support available
(including counselling and low vision assessment); risk
and improvement factors (such as the dangers of
smoking or the value of dietary changes); the import-
ance of continuing ocular exams; the date of their next
appointment and how to monitor vision (what to do if
they notice a change). The guidelines also recommend
several activities for patients to monitor dry AMD and
which may help identify wet AMD and thereby enable
earlier treatment to be given. These include: regular
ophthalmic examinations including optical coherence
tomography, avoiding bright sunlight, use of the
Amsler Grid8 (a grid with a central marker to focus on
—if lines around the central marker become wavy this
might indicate development of wet AMD) and advice
on the use of nutritional supplements which in some
patients may have a protective effect;9 changes in diet10
and smoking cessation.11 While some past research has
indicated the link between dissatisfaction with services
and perceptions of information provision in patients
with a variety of types of visual impairment12 13 little is
known about how well the RCOphth guidelines have
been incorporated into practice for patients with AMD.
This paper reports an exploratory study which exam-
ined patients’ experiences of eye health consultations
and their perceptions of information and support pro-
vision for AMD.
PARTICIPANTS AND METHOD
Between May and July 2010, ophthalmologists from spe-
cialist eye clinics identiﬁed patients diagnosed with AMD
and were judged capable of taking part in in-depth
interviews. Interested patients were given large print
information about the study to take away and agreed
that their contact details could be shared with the
research team. A few days later the participants were
contacted by telephone to answer any questions they
had about the research and to arrange a ﬁrst visit with
consenting participants. This study was granted National
Health Service (NHS) ethical approval from
Birmingham East, North and Solihull Research Ethics
Committee and research and development approval
from the relevant NHS trust.
Sociodemographic data were retrieved from patient
notes. In-depth semistructured interviews were used to
explore issues which were important to the participants
in their own words. The interview schedule included
questions focusing on experiences of diagnosis and
other eye care consultations, the impact of AMD and
related vision impairment on daily activities, relation-
ships with and/or support needs from family and
friends, and thoughts about the future. Perceptions and
experiences can change over time and interviews were
therefore carried out with each participant on up to
three occasions over 18 months to explore perceptions
of on-going encounters with healthcare professionals
(HCPs) during this time. Each interview was conducted
in the participants’ homes and lasted 1–2.5 h. Interviews
were conducted by the ﬁrst author, a research student,
who had no previous professional relationship with the
participants (further information about the interview
process has been published previously14). There was
some participant attrition: three participants declined
further involvement after the second interview stating
health reasons; and two participants were unable to be
contacted when arranging the third interview. A total of
34 interviews were conducted with 13 participants.
Follow-up interviews at 9 and 18 months began with
‘how have things been since the last time we met? ’.
Interviews were audiotaped, transcribed and analysis was
conducted guided by the ﬁve stages of thematic analysis
described by Braun and Clarke.15 These stages are:
familiarisation with the data, generating initial codes,
searching for themes, reviewing themes, and deﬁning
and naming themes. Theme development was com-
pleted using Nvivo V.10 software. The team (including a
practising ophthalmologist) held regular meetings
during the analysis process in which the developing
themes were discussed and agreed upon. Extracts from
the interviews are included in this paper to enhance the
transparency of the analysis. To ensure anonymity parti-
cipants chose their own pseudonyms.
RESULTS
Sample characteristics
Participants’ characteristics can be found in table 1.
Participant ages ranged from 75 to 89 with a mean age
of 81.5. Best eye visual acuity ranged from 6/6 to 6/30
while worst eye visual acuity ranged from 6/9.5 to hand
movements only (6/6 is the metric equivalent of 20/20
vision). Seven of the participants were eligible for treat-
ment and six were unable to be treated (two due to
having dry AMD and three had wet AMD which was too
advanced for treatment).
Sources of information
Information sources discussed by the participants
included: books, leaﬂets and ﬂyers; appointment letters;
public events, meetings and speeches; verbal informa-
tion in clinic; verbal information from opticians; and
information given by other people (friends, neighbours
and family members). Data extracts illustrating informa-
tion sources can be seen in box 1.
The most common source of information was verbal
information given in clinic at hospital appointments.
However the key problem with verbal communication
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was that many participants struggled to understand and
retain the information given. Three participants directly
discussed difﬁculties understanding verbal information,
problems included: hearing impairment (Rick),
difﬁculty with doctors’ accents (Mary, Rufﬁne) and
memory problems (Mary). It is likely that other partici-
pants also struggled to understand and retain informa-
tion given in clinic; though they did not refer to it
directly this was indicated by lack of understanding
about the cause of AMD (see cause attributions in
box 2), reasons for processes and procedures in clinic
(see ongoing information needs in box 2) and future
expectations about the condition (see box 4).
Letters were the second main source of information
and many described struggling to read letters with some
forced to ask others to read for them. For those being
treated for AMD the number of appointment letters
sent was overwhelming and confusing. In addition, the
wait for information through letters could be a frustrat-
ing time for participants.
Six participants described how they obtained informa-
tion from family, friends and other acquaintances. While
in some cases this could be a useful source of informa-
tion there was also a danger that the information
received and acted upon was inaccurate. For example,
these sources could suggest treatments were available
which were actually for other conditions giving a sense
of false hope: “Well, [name] had something done to his
eye at the hospital, didn’t he? Now, he can see better
[…] he had an operation and he can see perfect”
(Jack). Advice from non-professional sources also
resulted in patients feeling symptoms which should be
reported were nothing to be concerned about: “[I had]
a black cloud. My neighbor’s husband had it […]it
doesn’t last and I’ve heard a lot of people who say
they’ve had it but it went off after years and it’s come
back but not all of the time” (Mary). In addition, infor-
mation from peers could cause unwarranted distress
about experiencing total blindness: “it is really frighten-
ing, because I know somebody at one of my groups […]
Table 1 Participant characteristics
Pseudonym
Number
of
interviews Age Gender Diagnosis Treatable
Visual acuity*
Best
eye
Worst
eye
Rowans 2 77 Male Dry AMD both eyes No 6/9 6/12
Cathleen 2 80 Female Dry AMD both eyes No 6/7.5 6/9.5
Alison 3 85 Female Wet AMD both eyes Yes 6/9 6/12
Irene 2 86 Female Wet AMD one eye, dry AMD other eye Yes 6/7.5 6/30
Rose 2 89 Female Wet AMD one eye, dry AMD other eye Yes 6/9 6/12
Nuxy 3 78 Male Wet AMD one eye, dry AMD other eye Yes 6/7.5 6/12
Ruffine 3 82 Female Wet AMD one eye, no AMD other eye Yes 6/6 6/24
Jordan 3 75 Female Wet AMD both eyes Yes 6/36 6/60
Rick 3 82 Male Wet AMD one eye, no AMD other eye Yes 6/9.5 6/19
Hermione 3 80 Female Dry AMD and wet disconform scar No 6/15 CF
Jessie 3 87 Female Dry AMD and wet disconform scar No 6/24 6/120
Mary 2 82 Female Advanced wet AMD, other eye unknown No 6/9.5 HM
Jack 3 82 Male Advanced dry AMD and wet disconform
scar
No 6/30 CF
*Snellen visual acuity. In order from good vision to poor: 6/5; 6/6; 6/7.5; 6/9; 6/12; 6/18, 6/24, 6/36, 6/60, 6/60, 6/96.
AMD, age-related macular degeneration; CF, count fingers; HM, hand movements; PL, perception of light.
Box 1 Data extracts—sources of information
Verbal information given at hospital appointments: “This surgeon
said, ‘Of course, it’s the wear and tear and your age’. Which he
said quite a few times…and I thought, ‘I didn’t think anything
was wrong with my eyes’…I’ve always had pretty good eyesight.
So I suppose that it was a bit of a shock really.” (Irene)
Letters: “When I read all [these letters] I thought, err [date] [date]
[date] and I thought they’ve sent me these entire all at once, have
they slipped up? Which one am I supposed to have?” (Ruffine)
Opticians: “It worried me…It was when they wouldn’t answer me
and in the opticians when I said ‘is it serious?’ and not one of
them would answer they were just looking at me. That frightened
me, the life out of me, I thought it’s something very, very bad”
(Mary), “The optician was always very helpful with the information
he gave and what was wrong with your eyes and with your eye-
sight deteriorating and yeah he was very good, very good.”
(Nuxy)
Other people: “[I see] a black cloud. My neighbor’s husband had
it and they said it was nothing to worry about at the hospital
anyway, you know. But it doesn’t last and I’ve heard a lot of
people who say they’ve had it but it went off after years” (Mary)
Books, leaflets and flyers: “I read things [about AMD], sometimes
people give me bits out of the paper” (Cathleen), “I have got
some leaflets, I haven’t read them for ages” (Hermione)
Public events, meetings, speeches: “The social services woman
[at the meeting], she said, ‘is there anybody here that isn’t on
attendance allowance?’ and nobody put their hand up so they
was all on it, and I wrote for myself sort of thing, that when I
heard about this, well it was a bit of a, well they knew why it was
a bit, not as neat as I would liked it to be, and I got it straight
away.” (Jessie)
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who says she’s got dry macular, but she’s, she can’t write
her name, she, she’s virtually blind, so it isn’t just with
the wet macular that you can go blind, it’s with the dry
as well isn’t it?” (Cathleen).
Books, leaﬂets and ﬂyers were mentioned as a source
of information by just under half of the participants;
however, like letters these could be difﬁcult to access.
Some leaﬂets given by the hospital were unread and for-
gotten about. For example, Jessie described how her
granddaughter ‘ordered some booklets about help
which you can get’ but the act of reading was ‘difﬁcult’
because the words were ‘jiggling’ around and she con-
tinued to put off looking at the leaﬂets she had been
given: “one of these days I’ll sit down and study the lot”.
The other danger of ad hoc access to information
through books and newspapers was the risk of being
given inaccurate information. For example, Cathleen
explained that she collected newspaper cuttings, leaﬂets,
books, ‘all this lot, anything I ﬁnd’ and was at risk of
being overwhelmed by information: “I don’t know, you
just don’t know really what you’re doing.”
Five participants (Hermione, Jordan, Mary, Nuxy and
Rose) mentioned receiving information about their con-
dition from their optician. These participants reported
contrasting experiences of dealing with opticians with
some perceiving their appointments positively and
others negatively. For Mary her diagnosis experience was
made more stressful by the optician’s failure to
adequately inform her about what was happening (see
box 1).
Jessie and Alison discussed attending group meetings
and speeches about AMD as a source of information.
These sources were a good way to access information
they may not have had access to, and for Jessie they
enabled an application for attendance allowance which
may not have otherwise occurred.
Equipment and information from support services
All 13 participants discussed equipment provided and
the information received from HCPs and support ser-
vices and for many these highlighted information deﬁ-
cits. Deﬁcits were described across three time periods:
information needs prior to diagnosis; information needs
following diagnosis and ongoing information needs
throughout the course of the condition. Data extracts
relating to equipment and information from support ser-
vices are in box 2.
Box 2 Data extracts—equipment and information from support services
Prior to diagnosis
“Prior to [Diagnosis] I didn’t really know much about it at all…I think I’d vaguely heard about it, but I didn’t really know.” (Alison), “one
morning that the lampposts were all curly and that really frightened me, but I wasn’t sure what it was” (Hermione), “I didn’t realize that it
was so common. Until you go up there and when you see the amount of people about. You know, I’d never heard of it in actual fact. But
when you see the number of people at [hospital] especially, it’s always packed out.” (Nuxy)
Following diagnosis
Cause attributions: “We don’t really know what’s caused it.”(Jack), “When I was a little girl I put the scissors in the eye and of course that
weakened the right eye” (Mary), “I’d like to know what causes it, you know, anything I’ve done?” (Cathleen)
Processes and procedures: “I’ve got to go next month. So, whether they’ll [treat] the one eye today and then do the other eye next month, I
don’t know.”(Jordan), “Well, do you know what frightened me, [interviewer]? The photography, I thought it was never going to end. And it
was every 8 minutes he was coming in and your back was killing you in the high chair.” (Mary), “I’m going, as I say I’m going up there next
month, I don’t know what the procedure is going to be, but they don’t tell you do they? They don’t tell you.” (Rick)
Equipment and support services: “I have a horror of, not a horror, but I have, I don’t feel I want to be part of a group where everybody is,
or you might get some people who are, sadly, feeling very down about it, bless them, or grumbling about it, and you know? I can’t do this
and I can’t do that, and I’d rather not, and that probably isn’t the way it would work I’m sure not, but until I do need more help I haven’t.”
(Hermione), “I went to the, had the [Low vision assessment] test there, you know it’s very good, very good they were, but it’s so far away,
you know, being, on the buses and things like that, I’ve actually enquired how to get there but no one seems to know how I can get there
on the bus.” (Jessie), “Interviewer: Is there any support you’d like to receive that you are not receiving that would help you? Rick: I don’t
know what would be, support there is” (Rick)
Vitamins: “I got about five different lots which I took up [to the hospital]. I plonked than down and said ‘now tell me which are the best
ones?’. He said, ‘I Caps’. And I thought. ‘I can’t win’. He didn’t look at the others.”(Cathleen), “I was advised to take those [I-caps] and
that’s supposed to help it to not get any worse.”(Jessie)
Registering as blind or partially sighted: “He said that you could be registered as part-sighted. Well what does that mean? What does it do?
Does it open the door for different things?” (Jack)
Smoking: “I used to be a heavy, well I do, I still do smoke.” (Rick)
Activities you should and shouldn’t do: “I keep sort of thinking oh I will do [some painting] and I think no, I sort of put a limit on how
much I use my eyes a lot, does this make sense to you?” (Alison)
Ongoing information and support needs
Reasons for medical processes and procedures: “I have to go next month, I’m supposed to have the other eye done. Well, this is what I
could assume, it might be about today I don’t know.” (Jordan)
Registering as blind or partially sighted: “I mean someone said you could get more aids [if you registered as partially sighted] or something,
or like from different places, I don’t know.” (Jack)
How to monitor vision for changes (see self-advocacy theme in Box 3)
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Nine participants (Alison, Hermione, Irene, Jordan,
Mary, Nuxy, Rick, Rowans and Rufﬁne) talked about
issues which highlighted that they had little or no
knowledge of AMD prior to their eye care consult-
ation and as a result diagnosis came as a shock to
them.
A wide variety of information deﬁcits following diagno-
sis was evident in the accounts: the cause of AMD,
reasons for medical processes and procedures, vitamins,
registering as partially sighted, impact of smoking, foods
for eye health and activities they should or should not
pursue. These are all issues which the RCOphth guide-
lines recommend information to be provided for. Lack
of knowledge about the cause of AMD (various sug-
gested causes were discussed, ie, age, over use of the
eyes, eye trauma, previous treatments for eye conditions
and other medical conditions) links to the lack of knowl-
edge about AMD prior to diagnosis. Without prior
knowledge of AMD the participants lacked a frame of
reference on which they could make sense of their
newly diagnosed condition. In the case of AMD there is
a lack of knowledge ‘out there’ in society meaning
patients are totally dependent on the information given
to them by HCPs.
A lack of knowledge about the purpose of medical
processes and procedures was also highlighted. For
example, letters were often unclear about the purpose
of appointments. In addition during long 3–4 h appoint-
ments patients were not made aware of the purpose of
scans and other procedures. Despite the value of taking
vitamins and the recommendations for making patients
aware of these, only four participants (Cathleen,
Hermione, Jack and Jessie) discussed the use of vita-
mins, and all were unsure of their purpose or which
were the most beneﬁcial to take. Only two participants
(Jack and Jessie) mentioned the opportunity to register
as blind or partially sighted and both seemed uncertain
about the purpose and value of being registered. Three
participants reported smoking (Jordan, Rick and
Rufﬁne), and none discussed the impact this may have
on their eye health. Two participants (Alison and Jessie)
suggested they had given up activities they enjoyed
(reading and painting) in the hope that by doing this
they would use their eyes less and therefore preserve
their remaining vision. This myth about over use of the
eyes contributing to AMD may not be helped by HCPs
description of the condition as ‘wear and tear’ and
could be addressed by altering the way in which the con-
dition is explained to patients.
Few participants were aware of the support services
available to them. Many spoke of using magnifying
glasses and while some had been provided by social ser-
vices or charities others had bought equipment for
themselves. Despite knowledge of support groups there
seemed a fear that these groups were for people over-
whelmed by their condition and would not be enjoyable
to attend (“I know in many ways it’s a good idea because
you exchange ideas and you pick up tips but equally,
this sounds unkind, I know people tend to dwell some-
times on what is wrong with them and I personally don’t
think that’s a good thing in a group” Hermione).
Box 3 Data extracts—self-advocacy
Desire to be monitored by healthcare professionals: “I would like
an appointment. I would like a follow-up appointment. [The] Dr
said that if I’ve got any problems, just go to accident and emer-
gency.” (Cathleen), “The trouble is, at the eye hospital they exam-
ined my eyes and everything but they don’t give me a
follow-up.”(Jack), “They said, there is nothing we can really do he
said, we’ll see you in four months, and then we’ll see you in six
months and then you needn’t come again if you don’t want to but
if you want to you can, and I said, and I will! Because I would
rather remain under the hospital, because if there is an emer-
gency they’ve got it all there for you haven’t they?” (Mary),
“I know it’s a nuisance having to keep going but at least I know
that they will be checking on me you know?” (Ruffine)
Responsibility for monitoring vision and detecting changes:
“I mean, that’s another thing that the doctor said to me, about the
chart, the Amsler grid. It’s going, just at the top, on the right hand
side, it’s going wavy. And she said well don’t worry about that too
much. Well I thought that was the actual thing that I’d got to worry
about. You know, she’s just said when everyday objects start getting
all out of shape, then come back. And I thought I want to come back
before then. I want to know the minute it starts, it turns into a wet
macular. And I don’t know if I shall.” (Cathleen), “I mean it’s fine
isn’t it, for someone to say to you, well you would notice a change
because…but you can’t be sure…I’m not sure what I’m looking for!
I mean obviously if I suddenly couldn’t see or some dramatic
change, but would it be as dramatic as that?” (Hermione), “I am
going to see somebody about some aids, you know? Magnifying
glasses. But I had to ask… It must be terrible for elderly people who
perhaps can’t ask these things, you know? They must just be out,
and that’s it.”(Jack)
Box 4 Future expectations
Hope: “I am hoping obviously that…I’m hoping that this one
[eye] will return [to what it was]” (Alison) “Well the treatment I
suppose it’s peace of mind mostly. To think well at least I’m
responding to that treatment, it’s gone quite a lot better, and I’m
very pleased that it’s gone myself, which they are as well, so I
suppose the thought, the thought as well, we’re hoping anyway,
is it don’t get any worse now, and if that’s it I shall be very
pleased.” (Irene), “Well, I’m hoping that they stop like they are,
because I’m getting accustomed to it, and I’m hoping that those
(I-caps) work, that they’ll stabilise it”.(Jessie), “I just leave it at
the back of my mind and I think, don’t think of it too much at the
moment and hope it will be alright”. (Rowans)
Fear and Uncertainty: “I feel now… a bit in limbo, just waiting till
everyday objects go a peculiar shape.” (Cathleen), “I worry about
it a little bit because of the dependency later on, I do find just
occasionally in the night I wake, and I find I’m worrying about it.”
(Hermione), “I worry about shopping and it just managing the
basic things you know? I don’t think any farther than that really.”
(Jack) “I suppose I’ve got to put up with this now for the rest of
my life. I don’t think it’s a killing thing this is it [interviewer]?”
(Mary).
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There was a clear need for ongoing information across
the course of the condition. It seemed that an indivi-
dual’s information needs differed dependent on the
stage of the disease. Those with early AMD had a
greater need for information about monitoring their
condition and identifying changes. Patients with treat-
able wet AMD needed to know about the process and
outcomes of treatment. Once diagnosed with advanced
forms of the condition patients had a need for informa-
tion about available support services and equipment.
Evidence that some participants were unaware of what
support was available to them is concerning as the parti-
cipants described being expected to self-advocate and
identify their own needs.
Self-advocacy
Data extracts for this theme can be seen in box 3.
Almost half of the participants expressed a desire for
regular monitoring by HCPs. It seemed that the trad-
itional view of healthcare (HCPs are the experts, we tell
them our symptoms and they monitor our symptoms
and treat us) prevailed and therefore knowing that they
were under the care of the hospital gave a sense of
security. Those receiving treatment for wet AMD auto-
matically received on going appointments and those
with other conditions such as diabetes, cataracts or glau-
coma were also frequently monitored by other clinics
able to refer them back to an AMD clinic if additional
problems were identiﬁed. For participants with early or
advanced dry AMD or untreatable wet AMD there were
no regular appointments and most were discharged
from the hospital. These participants were often advised
to attend the Emergency Department (ED) if any pro-
blems with their vision occurred; however most were
uncertain of what changes they needed to identify and
how serious problems needed to be before they sought
assistance. Some of the participants referred to instruc-
tion to attend the ED as needing to attend ‘A&E’
(a service traditionally associated with accidents). These
patients may choose not to attend the ED as in their
minds it represents an A&E service which is designed
for accidents rather than the type of emergency they
were experiencing; a change in vision which would not
be considered an ‘accident’. This distinction in termin-
ology could have important implications for a patient’s
decision to seek help at the point of visual deterioration.
Eight of the participants (Alison, Cathleen, Hermione,
Jack, Jessie, Mary, Rowans and Rufﬁne) highlighted the
need to self-advocate; they were expected to identify
advancing vision loss and seek the appropriate support
as and when it was necessary. Most did not feel they
were adequately informed to identify any ‘big changes’
in vision that warranted a return to the hospital. This
again relates to patients lacking prior knowledge about
AMD and therefore not having a frame of reference on
which to base their experiences. In addition, the experi-
ence of vision loss was new to these patients making
their ability to describe and make sense of their
symptoms extremely challenging. Cathleen’s statement
‘I’m not sure what I’m looking for’ illustrated that she
did not possess the ﬁrst hand experiential knowledge to
be able to identify changes in her vision as instructed by
the HCPs whose clinical knowledge meant that identiﬁ-
cation of these changes represented a process for suc-
cessful diagnosis. The patient’s experiential knowledge
was clashing with the clinician’s expert knowledge
because the clinicians did not use language patients
could understand and relate to their own embodied
experience of worsening vision.
In addition some participants worried about bothering
the hospital and wasting hospital time unnecessarily.
Patients are likely to be aware of the ongoing media
speculation about the pressures on hospital services
which are being overwhelmed and this again may
impact on their decision to seek help from EDs. As
aforementioned, patients are unlikely to perceive
changes in vision as ‘accidents’ and therefore are reluc-
tant to become an added drain on overworked depart-
ments. Another example of self-advocacy is evident in
Jack’s description of sourcing his own appointment for a
low vision assessment.
Future expectations
The participants were all asked about their expectations
of their future with AMD, data extracts relating to this
theme are shown in box 4.
The responses fell into two main categories: fear and
uncertainty, and hope. Hope was more prominent in the
patients with treatable wet AMD as access to treatment
afforded them the prospect of improvement. In com-
parison, those with no possible treatment often spoke of
fear and uncertainty about what the future may be like.
The way a patient with AMD approaches their future,
either with hope or with fear, will have important impli-
cations for their adaptation to the condition. Cathleen,
for example was, “frightened of falling, you know, not
being able to see. You know not really being able to
cope” and this fear had fuelled her desire and search
for information. Unfortunately the majority of this infor-
mation came from ad hoc sources (as discussed previ-
ously) rather than directly from HCPs and as a result
fear continued to permeate Cathleen’s life. Had
Cathleen’s need for information been addressed more
formally in a healthcare context Cathleen perhaps
would have more conﬁdence to be able to identify and
monitor changes in her vision and prevent the ‘very
limited life’ that she feared. Information provision from
trusted sources in a format accessible to the individual
patient is vital for ensuring on-going mental well-being.
DISCUSSION
This study has given insight into the variety of informa-
tion deﬁcits which can be experienced by patients across
the spectrum of AMD forms and stages. There appear to
be deﬁciencies in current information provision and
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these ﬁndings demonstrate a need to ﬁnd ways to trans-
late the RCOphth guidelines into practice. This informa-
tion needs to be continually updated to reﬂect major
advances in the understanding of AMD, including the
role of genetics,16 the AREDS 2 study and its implications
for nutritional advice17 and advances in retinal imaging.
In addition, the information that patients require will
very much depend on their stage and type of AMD.
Patients with early and intermediate AMD, who still have
good vision, may beneﬁt from advice on nutritional infor-
mation and smoking cessation whereas patients with late
AMD probably will not beneﬁt from this advice.
It is clearly of concern that we have found that the
information in the current guidelines is not being
enacted and future work is required to determine
whether these deﬁciencies are typical and how to over-
come them. Based on these ﬁndings and our other ana-
lyses14 18 further work related to improving information
for patients with AMD is in development. While clinical
guidelines recommend that patients are given a wide
variety of information about their condition, the experi-
ences of these participants suggest that current informa-
tion provision may be insufﬁcient.
Recommended activities for older people, such as
taking supplements and changing diet, may play an
important role in reducing the risk of further visual
deterioration. However only four of the participants dis-
cussed taking recommended vitamins and for most this
was based on a speciﬁc recommendation made by a
healthcare practitioner. Participants did not seem aware
of the purpose and value of supplements and this may
have serious implications for adherence to regimens. For
example, in other eye conditions such as glaucoma it
has been suggested that compliance is often dependent
on beliefs about the efﬁcacy of the eyedrops.19 As vita-
mins and nutritional supplements are not generally pre-
scribed for AMD by the NHS (and therefore not
compulsory) their efﬁcacy may be questioned and this
may help to explain why adherence to recommended
supplement regimens has been reported to be low in
AMD patients.20
Some conditions, such as diabetes, have symptoms
which are more easily recognised as the result of
disease21; however, AMD symptoms involve changes in
visual ability which may be assumed to be a result of
‘normal ageing’. In these instances the individual may
not attribute their symptoms to a developing health con-
dition and instead accept them as a common complica-
tion of the ageing process; a conclusion which is
sanctioned by HCPs’ description of AMD as ‘wear and
tear’. Most of the participants in this study were unaware
of AMD prior to diagnosis and most were not adequately
informed about the course of their condition and
expressed fear about the future an issue which has been
shown to impact on patients’ satisfaction with ophthal-
mology services.22
Work exploring Parkinson’s disease, another unpre-
dictable condition in old age, has highlighted that
patients and HCPs have different sorts of knowledge
about living with a long-term condition and use differ-
ent strategies to manage the inherent uncertainty and
the anxiety diagnosis may provoke.23 HCPs may have
clinical expertise but patients have knowledge of what
living with the condition is like for them. In order to
improve practice HCPs need to see patients as more
than ‘diseased bodies’ and attempt to empathise and
understand how being diagnosed with a long-term con-
dition and dealing with the healthcare service feels from
a patient’s perspective.24
Research within ophthalmic practice conﬁrmed that
patients want information tailored to their needs and
that this is vital to ensure that patients play an active role
in the management of their condition.24 The fear and
uncertainty reported in this study illustrates that patients
may need improved support and reassurance from HCPs
who understand what it is like to live with AMD. Patients
need more than medical treatment for their condition
and may need counselling or emotional support to
enable them to cope with the changes AMD causes to
their lives, roles and self-concepts.14 This change in
outcome is dependent on a change in the behaviour of
HCPs whose role in patient–professional interactions has
important implications for a patient’s experience of the
condition.25 26
This change in approach to information provision is
imperative in a practice model which expects patients
with AMD to identify important changes in their vision
and seek appropriate and timely support. As already
highlighted many patients lack the knowledge necessary
to be able to self-advocate; an issue commonly over-
looked when caring for patients with visual impair-
ment.27 An additional problem is encountered through
the discontinuity of services which are spread across
sectors within the UK. While the NHS provides ophthal-
mology clinics through referral from private high street
optometrists there are also a number of third sector
organisations offering support (ie, Royal National
Institute of Blind People; RNIB, Macular Society, etc).
These third sector support services are well placed to
play a key role in the provision of information and
support in order to relieve the pressure on ophthalmolo-
gists. At present patients need to be proactive in seeking
this support and a more structured care pathway should
be developed to ensure patients access third sector
support following consultation.
Another key problem is the way in which information
is delivered to patients. Current guidelines suggest
written and verbal information should be provided,
however the stress of diagnosis may result in verbal infor-
mation being forgotten, while visual impairment may
reduce ability to access written material. This may leave
patients confused about what is required of them and
therefore unable to play an active role in managing
AMD. In addition, while services may be offered to
patients soon after diagnosis the progressive nature of
AMD and changing environmental demands may
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require on-going adaption by the patient. Once dis-
charged, services may become increasingly difﬁcult to
access.25 Our study has shown that patients have differ-
ing information needs before, after and in the long-term
following diagnosis. Support should not end at the point
of discharge. Patients with AMD need ongoing oppor-
tunities to be offered follow-up and support across the
course of the condition.
Recommendations for practice
To ensure a patient-centred approach to future services
for patients with AMD there is a need to develop a care
pathway incorporating adequate and appropriate infor-
mation provision that bolsters a patient’s self-efﬁcacy
and self-advocacy. Information provision for patients
needs to be improved and become less reliant on
written and verbal methods which may be unsuitable for
many patients. In addition HCPs need to do more to
understand the perspectives of individual patients in
order to help them assimilate information and make
sense of the progressive condition with which they have
been diagnosed. This often requires more than medical
intervention and illustrates a need for ophthalmology
patient pathways to include referral to counselling and
social support services to help the patient come to terms
with and adjust to progressive vision loss. These services
need to be easily accessed by patients even after the
point of discharge and patients therefore need regular
follow-up appointments to assess their physical, social
and psychological needs.
Limitations of the study
Qualitative methods traditionally use smaller samples to
ensure that the depth and detail of participant accounts
can be fully understood. In addition recruitment for this
study took place in a busy clinic meaning that a purpos-
ive form of sampling would be challenging. Despite
this the sample included patients with a range of AMD
conditions and all participants highlighted a variety of
information deﬁcits experienced. As all participants
experienced elements of information deﬁcit this lends
support to our arguments regarding improved informa-
tion provision for patients. In addition, data collection
for this study took place in 2010 and given that the
RCOpth guidelines were published in 2009, this may not
have allowed enough time for the guidelines to be trans-
lated into practice. Conclusions from these data about
‘current’ practice should be interpreted with caution
and as nearly 3 years have passed since the data were col-
lected, experiences of patients with AMD may now be
different. Despite this the results provide a valuable start-
ing point to further investigate the issues raised.
CONCLUSION
This study has highlighted many areas where further
research is needed to address the information needs of
patients with AMD and to design services to ensure they
receive the best possible care, and up to date informa-
tion. New ways to deliver information need to be devel-
oped to ensure this is understood and retained and
patients are motivated to take steps to monitor and pre-
serve their vision. HCPs need to be educated about the
best ways to communicate with patients to ensure that
care is patient focused.
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